MyMD Pharmaceuticals, Inc.

NASDAQ:MYMD

1.81 (USD) • At close July 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 00001.5771.6663.932.9612.1154.4273.5781.5221.7853.0531.8446.0785.5191.0214.61
Cost of Revenue 0000.0290.0741.5381.421.0830.9511.1751.9140.9760.8951.2881.1011.3712.0142.4642.94
Gross Profit 000-0.0291.5030.1272.511.8781.1643.2521.6640.5460.8911.7660.7434.7073.505-1.4431.67
Gross Profit Ratio 00000.9530.0760.6390.6340.550.7350.4650.3590.4990.5780.4030.7740.635-1.4130.362
Reseach & Development Expenses 7.8689.0676.7452.4673.6281.0631.261.1891.4070.9161.0070.7170.6980.6750.6620.4320.1260.7870.79
General & Administrative Expenses 5.4436.21521.4565.8115.7655.6664.0823.0094.033.9791.5251.493.2781.8864.3120.1520.28300
Selling & Marketing Expenses 8.487000.0230.2381.7822.0492.1372.5431.3020.6850.6390.708000000
SG&A 8.4926.21521.4565.8113.3237.4486.1315.1466.5735.2812.2092.1283.9861.8864.3120.1520.28300
Other Expenses -0.763000.0180.040.1710.1710.1710.2370.2590.2590.320.0590.3370.4352.1064.8376.5993.086
Operating Expenses 17.12315.28328.2018.2963.3238.6837.5626.5068.2166.4563.4753.1664.7432.8985.4092.6895.2467.3863.876
Operating Income -17.123-15.283-28.81-9.488-3.397-8.555-5.053-4.628-7.052-3.204-1.811-2.619-3.853-1.133-4.6662.018-1.741-8.829-2.205
Operating Income Ratio 0000-2.154-5.137-1.286-1.563-3.334-0.724-0.506-1.721-2.158-0.371-2.530.332-0.315-8.648-0.478
Total Other Income Expenses Net 13.1230.085-1.07900.016-2.294-0.7531.325-2.5290.0770.2840.007-0.029-0.0710.038-3.253-0.624-1.255-2.302
Income Before Tax -4-15.197-29.889-9.488-3.381-10.849-5.805-3.304-9.581-3.127-1.527-2.612-3.882-1.203-4.628-1.235-2.365-10.084-4.507
Income Before Tax Ratio 0000-2.144-6.514-1.477-1.116-4.53-0.706-0.427-1.716-2.175-0.394-2.51-0.203-0.429-9.877-0.978
Income Tax Expense 4.218-0.085-0.0091.192-0.084-2.294-0.7531.325-0.2690.0160.284-0.163-0.298-0.2830.038-0.7-0.64-0.4890
Net Income -4-15.112-29.88-10.68-3.888-10.849-5.805-3.304-9.312-3.127-1.527-2.449-3.584-0.92-4.628-0.535-1.725-9.595-4.507
Net Income Ratio 0000-2.466-6.514-1.477-1.116-4.403-0.706-0.427-1.609-2.008-0.301-2.51-0.088-0.312-9.398-0.978
EPS -2.59-11.68-25.6-90.86-380.79-23.73-117.39-116.81-347.78-126.52-183.59-411.4-657.79-240.93-1,221.43-257.54-829.94-5,063.14-2,697.3
EPS Diluted -2.59-11.68-25.6-90.86-380.79-23.73-117.39-116.81-347.78-126.52-183.59-411.4-657.79-240.93-1,221.43-257.54-829.94-5,063.14-2,697.3
EBITDA -17.123-15.199-28.192-8.278-3.323-10.615-5.555-3.017-9.281-2.778-1.172-2.075-3.357-0.719-3.7080.593-1.741-8.829-3.857
EBITDA Ratio 0000-2.107-6.373-1.414-1.019-4.388-0.627-0.328-1.363-1.881-0.236-2.010.097-0.315-8.648-0.837